Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Research

The burden of rotavirus-related illness among young children on the Australian health care system

To provide estimates of the annual number and cost of hospital admissions, emergency department (ED) visits and general practitioner (GP) visits...

News & Events

Skin infections send eight out of every 100 Aboriginal babies to hospital

In a WA first, researchers from The Kids Research Institute Australia have shown that Aboriginal babies are 22.5 times more likely to be treated for skin infections than non-Aboriginal babies.

News & Events

The Kids Research Institute Australia researcher awarded support funding

A Kids Research Institute Australia researcher has been awarded $10,000 from the New Independent Researcher Infrastructure Support (NIRIS) award.

News & Events

Celebrating 20 years of meningitis awareness

Australian charity celebrates 20 years of providing meningitis awareness and marks World Meningitis Day with footy star

News & Events

Perth trial begins on investigational Golden Staph vaccine

Perth researchers are calling for volunteers to help test an investigational vaccine against Staphylococcus aureus (golden staph).

News & Events

Volunteers needed to trial new vaccine against dengue fever

Perth researchers are about to trial a new vaccine that aims to protect against all four strains of the potentially devastating Dengue Fever.

News & Events

Infections leave life-long scars

High rates of recurrent infection are a major risk to the health of Aboriginal children and are comparable to those of third world countries.

Research

STopping Acute Rheumatic Fever Infections to Strengthen Health (STARFISH)

STopping Acute Rheumatic Fever Infections to Strengthen Health (STARFISH) brings together a diverse and multidisciplinary research team to investigate the most effective environmental health initiatives (EHIs) aimed at reducing Strep A infections and prevent Acute Rheumatic Fever (ARF).

Research

A Systematic Framework for Prioritizing Burden of Disease Data Required for Vaccine Development and Implementation: The Case for Group A Streptococcal Diseases

Vaccine development and implementation decisions need to be guided by accurate and robust burden of disease data. We developed an innovative systematic framework outlining the properties of such data that are needed to advance vaccine development and evaluation, and prioritize research and surveillance activities.